AddLife (OM:ALIF B) Stock May Be 18% Undervalued On Cash Flow
AddLife has had a mixed share-price story in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current price around its recent close really aligned with the cash flows the healthcare supplier is expected to generate? Over the past 3 years, AddLife has delivered a very large return of about 216.5%, which puts a lot of weight on whether its cash generation can sustain that kind of re-rating. The business model leans heavily on recurring...
AddLife has had a mixed share-price story in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current price around its recent close really aligned with the cash flows the healthcare supplier is expected to generate? Over the past 3 years, AddLife has delivered a very large return of about 216.5%, which puts a lot of weight on whether its cash generation can sustain that kind of re-rating. The business model leans heavily on recurring...
What's Your Reaction?
